September 22, 2016 / 6:41 AM / 13 days ago

BRIEF-Genomic Vision: Capital Increase Of EUR 1.0 Mln Within Framework Of Financing Contract Signed With Winance

Feb 11 (Reuters) - GENOMIC VISION SA:

* GENOMIC VISION ANNOUNCES THE ACCEPTANCE NOTICE OF THE THIRD TRANCHE OF €1.0 MILLION WITHIN THE FRAMEWORK OF THE EQUITY FINANCING PUT IN PLACE WITH WINANCE

* INITIATED PROCESS OF ISSUING 2,777,778 NEW SHARES AT A UNIT PRICE OF EUR 0.36, CORRESPONDING TO A CAPITAL INCREASE OF EUR 1.0 MILLION

* CAPITAL INCREASE OF EUR 1.0 MILLION WITHIN FRAMEWORK OF FINANCING CONTRACT SIGNED WITH WINANCE

* FOLLOWING THIS OPERATION, SHARE CAPITAL OF GENOMIC VISION WILL CONSIST OF 41,297,623 SHARES

* NEW SHARES WILL BE FREELY TRADABLE AND IMMEDIATELY ASSIMILATED TO EXISTING ORDINARY SHARES LISTED ON EURONEXT MARKET IN PARIS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below